Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
Infectious Diseases and Therapy (2021) - Comments
pubmed: 33977506  doi: 10.1007/s40121-021-00453-3  issn: 2193-8229  issn: 2193-6382 

Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David Willms, George Sakoulas